These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24669252)

  • 1. Effects of resveratrol on cell growth and prolactin synthesis in GH3 cells.
    Chao W; Xuexin Z; Jun S; Ming C; Hua J; Li G; Tan C; Xu W
    Exp Ther Med; 2014 Apr; 7(4):923-928. PubMed ID: 24669252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol inhibited GH3 cell growth and decreased prolactin level via estrogen receptors.
    Wang C; Hu ZQ; Chu M; Wang Z; Zhang WG; Wang LZ; Li CG; Wang JS
    Clin Neurol Neurosurg; 2012 Apr; 114(3):241-8. PubMed ID: 22104698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor, insulin, and estrogen stimulate development of prolactin-secreting cells in cultures of GH3 cells.
    Kakeya T; Takeuchi S; Takahashi S
    Cell Tissue Res; 2000 Feb; 299(2):237-43. PubMed ID: 10741464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor antagonist fulvestrant inhibits proliferation and promotes apoptosis of prolactinoma cells by regulating the IRE1/XBP1 signaling pathway.
    Wang C; Bai M; Wang X; Tan C; Zhang D; Chang L; Li G; Xie L; Su J; Wen Y
    Mol Med Rep; 2018 Oct; 18(4):4037-4041. PubMed ID: 30106152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis.
    Lee SY; Ahn BT; Baik SH; Lee BL
    Neurosurgery; 1998 Jul; 43(1):116-23. PubMed ID: 9657197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation and action of estrogen receptors alpha and beta in GH3 cells.
    Mitchner NA; Garlick C; Steinmetz RW; Ben-Jonathan N
    Endocrinology; 1999 Jun; 140(6):2651-8. PubMed ID: 10342855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coculturing posterior pituitary and GH3 cells: dramatic stimulation of prolactin gene expression.
    Corcia A; Steinmetz R; Liu JW; Ben-Jonathan N
    Endocrinology; 1993 Jan; 132(1):80-5. PubMed ID: 8419149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting MAPK14 showed anti-prolactinoma effect.
    Ding QY; Zhang Y; Ma L; Chen YG; Wu JH; Zhang HF; Wang X
    BMC Endocr Disord; 2020 Sep; 20(1):138. PubMed ID: 32894113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.
    Kansra S; Yamagata S; Sneade L; Foster L; Ben-Jonathan N
    Mol Cell Endocrinol; 2005 Jul; 239(1-2):27-36. PubMed ID: 15950373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of estrogen and estrogen receptor antagonist, ICI 182 780, on the expression of calbindin-D9k in rat pituitary prolactinoma GH₃ cells.
    Wang W; Knosp E; Tai G; Zhao Y; Liang Q; Guo Y
    Int J Clin Exp Pathol; 2014; 7(12):8498-505. PubMed ID: 25674214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of serum and stimulatory effects of estrogen on prolactin mRNA levels in GH3 rat pituitary tumor cells.
    Rhode PR; Gorski J
    Mol Cell Endocrinol; 1991 Nov; 82(1):1-9. PubMed ID: 1761162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of mammotroph development by a combination of epidermal growth factor, insulin, and estradiol-17beta in rat pituitary tumor GH3 cells.
    Kakeya T; Takeuchi S; Takahashi S
    Zoolog Sci; 2002 Jul; 19(7):789-95. PubMed ID: 12149580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of bone morphogenetic proteins in prolactin regulation by somatostatin analogs in rat pituitary GH3 cells.
    Tsukamoto N; Otsuka F; Miyoshi T; Inagaki K; Nakamura E; Suzuki J; Ogura T; Iwasaki Y; Makino H
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):163-9. PubMed ID: 20970474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous expression of Neuregulin-1 (Nrg1) as a potential modulator of prolactin (PRL) secretion in GH3 cells.
    Zhao W; Shen Y; Ren S
    Cell Tissue Res; 2011 May; 344(2):313-20. PubMed ID: 21437657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mastoparan-stimulated prolactin secretion in rat pituitary GH3 cells involves activation of Gq/11 proteins.
    Yajima Y; Uchino K; Ito H; Kawashima S
    Endocrinology; 1997 May; 138(5):1949-58. PubMed ID: 9112392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the prolactin promoter in transfected GH3 cells by posterior pituitary cells.
    Steinmetz R; Gutierrez-Hartmann A; Bigsby RM; Ben-Jonathan N
    Endocrinology; 1994 Dec; 135(6):2737-41. PubMed ID: 7988465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells.
    Song JY; Jin L; Lloyd RV
    Cancer Res; 1989 Mar; 49(5):1247-53. PubMed ID: 2917354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prosurvival role of autophagy in resveratrol-induced cytotoxicity in GH3 cells.
    Zhang X; Xu W; Su J; Chu M; Jin H; Li G; Tan C; Wang X; Wang C
    Int J Mol Med; 2014 Apr; 33(4):987-93. PubMed ID: 24534837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential binding of GH3 and pituitary protein extracts to the estrogen-dependent enhancer of the rat prolactin gene.
    Meier DA; Gorski J
    Mol Cell Endocrinol; 1991 Jan; 75(1):19-26. PubMed ID: 2050264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane estrogen receptor-alpha-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells.
    Jeng YJ; Kochukov MY; Watson CS
    J Mol Signal; 2009 Apr; 4():2. PubMed ID: 19400946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.